Expert Interview
Discussing the potential of Roivant's batoclimab for normalizing of T3 and T4 hormone levels in patients with Graves’ disease
Ticker(s): ROIV, IMVTInstitution: Mayo Clinic
- Chair of the Thyroid Core Group for the Division of Endocrinology at Mayo Clinic
- Treats 150 patients with Graves' Disease every year
- Clinical interest in the area of autoimmune thyroid diseases, with a specific interest in Graves' disease and Graves' ophthalmopathy; Research aims to identify novel treatments as well as methods of prevention for these condition, in both retrospective reviews of cases and clinical trials
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
